Growth hormone therapy in progeria

J Pediatr Endocrinol Metab. 2007 May;20(5):633-7. doi: 10.1515/jpem.2007.20.5.633.

Abstract

Catabolic processes seen in Hutchinson-Gilford progeria resemble those of normal aging and, in the affected children, usually result in death at an early age. In addition to its growth promoting effects, growth hormone (GH) has potent anabolic properties. Administration of GH ameliorates some of the catabolic effects of normal aging. We report the results of GH treatment in a young child with progeria.

Publication types

  • Case Reports

MeSH terms

  • Aging, Premature / genetics
  • Child, Preschool
  • Fatal Outcome
  • Growth Hormone / therapeutic use*
  • Humans
  • Laminin / genetics
  • Male
  • Mutation
  • Progeria / drug therapy*
  • Progeria / genetics

Substances

  • Laminin
  • laminin A
  • Growth Hormone